EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selected Thieno[2,3-d] Pyrimidine Derivatives Target Breast Cancer Cell Proliferation and Membrane Organization

Aleksandrina Nesheva, Ivan Iliev iD, Anelia Mavrova iD, Denitsa Yancheva iD, Aneliya Kostadinova iD, Severina Semkova, Albena Momchilova, Iana Tsoneva iD, Biliana Nikolova iD, Galya Staneva iD

Molecules · 11.07.2026 · 31 (14) · 2435

DOI: 10.3390/molecules31142435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 11.07.2026. Verfasst von Aleksandrina Nesheva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 21, 1113 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Pyrimidines, Breast Neoplasms, Antineoplastic Agents, Cell Membrane. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian Science Fund, Sofia , Bulgaria, National Science Fund of Bulgaria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide, highlighting the urgent need for novel therapeutic agents with improved efficacy and selectivity. In this study, we investigated the anticancer potential of selected thieno[2,3-d]pyrimidine-based hybrids in breast cancer cell models with different metastatic potential. The compounds were evaluated for their effects on cell viability, clonogenic survival, migration, cell-cycle progression, cytoskeletal organization, and plasma membrane organization. Several derivatives exhibited concentration-dependent antiproliferative activity, inhibited colony formation and cell migration, disrupted cytoskeletal integrity, and modulated plasma membrane organization. Cell-cycle analysis revealed compound- and cell line-dependent alterations in the distribution of cells across the G1, S, and G2/M phases. Among the tested compounds, derivatives 1, 5, and 6 displayed the most favorable biological profiles, combining antiproliferative activity with moderate selectivity toward breast cancer cells, whereas compound 2 exerted the most pronounced effects on plasma membrane organization and cell migration. Collectively, these findings identify selected thieno[2,3-d]pyrimidine-based hybrids as promising lead compounds for the development of novel anticancer agents targeting both tumor cell proliferation and plasma membrane organization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesBreast NeoplasmsAntineoplastic AgentsCell MembraneHumansCell ProliferationFemaleCell MovementCell Line, TumorCell CycleCell SurvivalStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

actin cytoskeletonbreast cancer cellscell-cycle arrestclonogenic survivalplasma membrane organizationselective cytotoxicitythieno[2,3-d]pyrimidine scaffold

Substanzen

PyrimidinesAntineoplastic Agentsthieno(2,3-d)pyrimidine

Autor:innen und Institutionen

  • Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 21, 1113 Sofia, Bulgaria.
  • Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 25, 1113 Sofia, Bulgaria.
  • Department of Organic Synthesis, Faculty of Chemical Technologies, University of Chemical Technology and Metallurgy, S8 Kliment Ohridski Blvd., 1756 Sofia, Bulgaria.
  • Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 9, 1113 Sofia, Bulgaria.

ORCID-Profile: Ivan Iliev, Anelia Mavrova, Denitsa Yancheva, Aneliya Kostadinova, Iana Tsoneva, Biliana Nikolova, Galya Staneva

Förderung

  • Bulgarian Science Fund, Sofia , Bulgaria
  • National Science Fund of Bulgaria

Zitieren

APA

Nesheva, A., Iliev, I., Mavrova, A., Yancheva, D., Kostadinova, A., Semkova, S., Momchilova, A., Tsoneva, I., Nikolova, B., & Staneva, G. (2026). Selected Thieno[2,3-d] Pyrimidine Derivatives Target Breast Cancer Cell Proliferation and Membrane Organization. Molecules, 31(14), 2435. https://doi.org/10.3390/molecules31142435

Vancouver

Nesheva A, Iliev I, Mavrova A, Yancheva D, Kostadinova A, Semkova S, et al. Selected Thieno[2,3-d] Pyrimidine Derivatives Target Breast Cancer Cell Proliferation and Membrane Organization. Molecules. 2026;31(14):2435. doi:10.3390/molecules31142435

BibTeX
@article{Nesheva2026,
  author = {Nesheva, Aleksandrina and Iliev, Ivan and Mavrova, Anelia and Yancheva, Denitsa and Kostadinova, Aneliya and Semkova, Severina and Momchilova, Albena and Tsoneva, Iana and Nikolova, Biliana and Staneva, Galya},
  title = {Selected Thieno[2,3-d] Pyrimidine Derivatives Target Breast Cancer Cell Proliferation and Membrane Organization},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {14},
  pages = {2435},
  doi = {10.3390/molecules31142435}
}
Kostenlos starten →